doi: 10.1093/oxfordjournals.aje.a010290 43
Optimal Dosing Schedule" as a peptide therapy guide where research status, sourcing, compounding quality, dosing, and clinician oversight all need extra scrutiny
Darifenacin has a 12 fold higher selectivity for M3 compared to M1 & M5, 59-fold greater selectivity for M3 vs M2 & M4 (rxlist.com)
Genetic factors may play a role, as many patients report family members with similar symptoms
Who Should Proceed With Caution Men with a history of hormone-sensitive cancers Those with uncontrolled diabetes or significant metabolic disease Men with active cardiovascular conditions Anyone with pituitary disorders Those taking medications that may interact with hormone therapies What to Expect: Timeline of Results Results from a peptide and TRT stack develop progressively: Individual timelines vary based on starting hormone levels, age, training status, and adherence to the protocol
Step 2: Need an Instant Glow